P75342 AF NFT

Uncharacterized lipoprotein MG307 homolog

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeih2blal5cux352izsa4qk5jue3dynim2qw6uwo5pkxjgq53sg47qu/metadata.json
IPFS of structure file: 
bafybeicxefo3s77qflqcyzln3rhxxhkjkqznp6hthclo563uszd7lcxgpm/AF-P75342-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7FDF8b382C6a36A8772D1A265E8e480c7DF0A9C1
First NFT owner address (bech32): 
genesis10l0ckwpvdgm2saedrgn9arjgp37lp2wpyzq5qn
Current NFT ID #517462 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
517462
Accession (UniProt):
P75342
Name::
Uncharacterized lipoprotein MG307 homolog
Experimental Method:
Predicted structure
Sequence source:
MYCOPLASMA PNEUMONIAE (STRAIN ATCC 29342 / M129)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P75342 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P75342|Y436_MYCPN Uncharacterized lipoprotein MG307 homolog OS=Mycoplasma pneumoniae (strain ATCC 29342 / M129) OX=272634 GN=MPN_436 PE=3 SV=1 MKKFLRKPQFWLLTLGGFLSTSVILAACATPSNSALQTVFKARSSQFFNGEQGSLQSALTTALKNPVANKQFIAAPLLKALEAWYENNEDKKITQFLKDTKSNVDSQYTTAVDKVVSASRNKSLFVQQDLLDNAGGSEATWKAQKLLEQLISDFASRVFQKNYLNYKKDGQVSTGPFTYDELHKEESWKNFEFSAPRFSETNDDFFAKIQSQVFDQWVEYTDPTLISQVNYKYSAPSQGLGQIYNREKLKDKLTPSYAFPFFAEEKDIAPNQNVGNKRWKQLVKGEGAITDNNIGQSGTNSQKTGLLKYRNESNKGDFLDFPLNLSDTNETKQLVDASNIVDQLEAANLGAALNLKLQVFEQDNDELPQIKELKEDLNNTIVVDKSKDVEKASKTNALFYNDQEGKQQQSDSDPIAGALDDIFAQNTSEGTNLSKLAEQVKKAAATKMEAKTAVLRTNNSKGQQNNYVVLDAAIPTFNSTTSKSKNNSASNEVLVALKSGSINLRQVQQTDQNSYSPIKFRIVRNSTGVTVFGLDGGSYYLKQDSTNKKSVSKQSLTLLTKSSSGNSNKVLRDLDKQKQFLKFRAFQAKTNTFYSTNFAFSFPLNETLKSWFDKHRELILANALVNASLDQKDKASKALTEAFNPYKELIKEFAPVALATTMISFYFDQMKALNNKLLERARNLNQNVNQANPTPWLNGLSAKLPYVNTNGNYEKLNNYFTFLITKTLWPKVGQEETSISEESNKLKTKTADVDKIRDKILENIQTKVNDFVKNKLKPALAPRPAYSNVILLNVNNDKVLSSGANWSLASLLQSDKVNPLSFMLLKQAFDNNDLFKKAQKLFKDIQEKSSNNGGMQSSSTTNSDADALSKVIGNYYYTTWAKLTDKSIYGNPKDNKFDELFKLAFEASIDEKSFNVDYKAVIDHYRFIYTLQWLVDQKLKNFKSLLKTNLKFGEVAFIAYKNTETTNFSNPQGVFGSYFNYENSASEVKESTQTLDPNNFFYKTTTKPTVQAIQQVASLALVQKQQMQQNSTDHYGFTGLSTSTSSMFDASSRDAILQQITKTSLQQYGSKDQLKKIIQGTNNQLLLDRIAVQLSGLNPSTTNGGSGKTIATYFQVDAVGNPTLDFQAKRKLLLDLLDQYQNYFGNGAQKSQRDSTPSGTGNYLTYQNGSDKYTYTQFTYQDIDSLSLTTTSGTNNKIASDVVAALLLFQAADKGTQQLALSAINKPQLNIGDKRIESGLKLLK